Altium Capital Management LP 2seventy Bio, Inc. Transaction History

Altium Capital Management LP

  • $283 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$12.56 - $17.54 $715,920 - $999,780
57,000 Added 68.67%
140,000 $2.04 Million
Q2 2022

Aug 15, 2022
SELL
$10.55 - $18.81 $337,600 - $601,920
-32,000 Reduced 27.83%
83,000 $1.1 Million
Q1 2022

May 16, 2022
BUY
$11.67 - $26.72 $1.34 Million - $3.07 Million
115,000 New
115,000 $1.96 Million

Others Institutions Holding TSVT

# of Institutions
126
Shares Held
45.6M
Call Options Held
122K
Put Options Held
19.8K
View Full List

About 2seventy bio, Inc.

TSVT Quotes by TradingView
  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email